On Tuesday, Prologis Inc(NYSE:PLD)’s shares declined -1.35% to $38.14.
Menlo Logistics (Menlo), the US$1.7 billion global logistics and supply chain administration partner of Con-way Inc. (CNW), recently declared a build-to-suit agreement with global industrial real estate developer Prologis, Inc. (PLD) for a new 70,000-square-meter regional logistics facility in Eindhoven, the Netherlands.
The facility will be located at the Acht industrial park in Eindhoven, adjacent to the A2/N2 Eindhoven ring road, which offers direct access to Belgium and Germany, in addition to Amsterdam to the north. It will be one of the largest build-to-suit projects in the region. The expansion spotlights Menlo’s commitment to investing in the expanding market for high-value warehousing, distribution and fulfillment services in the Benelux region, and its growing prominence as a planned logistics hub for central Europe.
The new Eindhoven facility complements Menlo’s European footprint, which comprises a network of 16 facilities throughout Europe staffed by 800 employees. The company services more than 30 European businesses and multinational companies in sectors such as healthcare, fashion and apparel, consumer goods, e-commerce, high-tech, industrial manufacturing and automotive.
Prologis Inc. is an independent equity real estate investment trust. It invests in the real estate markets across the globe. The firm engages in the ownership, development, administration, and leasing of industrial distribution and retail properties.
Scripps Networks Interactive, Inc. (NYSE:SNI)’s shares dropped -2.80% to $51.03.
Seven teams comprising of a cake artist, sugar sculptor and master food carver go head-to-head this holiday season in the ultimate sugar-packed competition trying to outdo each other with their outrageous holiday cake displays on Food Network’s Cake Wars: Christmas, premiering on Monday, November 9th at 9:00pm ET/PT. Over the course of the six exhilarating one hour episodes, hosted by Jonathan Bennett, the teams will battle it out in two rounds of challenges to design over-the-top cake confections. First, in the Stocking Stuffer Challenge, it is a race against the clock to create an edible Christmas-themed cake. One team will earn a vital advantage in Santa’s Mega Challenge, where the teams must create an eye-popping, larger-than-life masterful cake displays. Holiday crafter extraordinaire Charles Phoenix and renowned pastry chef Sherry Yard, in addition to special guest judges will decide who will jingle all the way home with the $50,000 grand prize.
Fan can visit FoodNetwork.com/CakeWars for photos of the festive, eye-popping creations from the show and watch behind-the-scenes videos featuring Jonathan Bennett and the judges. They can also join the conversation on Twitter using #CakeWars.
Scripps Netoperates Interactive, Inc. develops lifestyle-oriented content for linear and interactive video platforms in the United States, the United Kingdom and other European markets, the Middle East and Africa, the Asia-Pacific, and Latin America. The company delivers content that focuses on specifically defined topics of interest for audiences and advertisers.
At the end of Tuesday’s trade, Seattle Genetics, Inc. (NASDAQ:SGEN)‘s shares surged 0.09% to $44.66.
Seattle Genetics, Inc. (SGEN) recently declared the pricing of an underwritten public offering of 11,707,318 shares of its common stock at a price to the public of $41.00 per share. All of the shares are being sold by Seattle Genetics. The gross proceeds to Seattle Genetics from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are predictable to be about $480 million. The offering was upsized by 20 percent from the originally anticipated gross offering amount of $400 million. The offering is predictable to close on or about September 16, 2015, subject to customary closing conditions. In addition, Seattle Genetics has granted the underwriters of the offering a 30-day option to purchase up to an additional 1,756,097 shares of its common stock at the public offering price, less the underwriting discounts and commissions, solely to cover overallotments.
Seattle Genetics anticipates using the net proceeds from the offering to fund the ongoing commercialization of ADCETRIS® (brentuximab vedotin) in the United States and Canada, to fund its research and development efforts designed to further expand the ADCETRIS label and to advance its pipeline of product candidates, in addition to for general corporate purposes, counting working capital.
Seattle Genetics, Inc., a biotechnology company, develops and commercializes antibody-based therapies for the treatment of cancer. The company is developing antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of antibodies to deliver cell-killing agents directly to cancer cells.
Dicks Sporting Goods Inc (NYSE:DKS), ended its Tuesday’s trading session with -1.10% loss, and closed at $49.31.
DICK’S Sporting Goods (DKS), the largest U.S.-based, full-line omni-channel sporting goods retailer, will be opening its 10th store in Wisconsin and 631st store nationwide on Friday, October 2nd at the Janesville Mall in Janesville, WI (2500 Milton Avenue).
DICK’S three-day grand opening celebration will run through Sunday, October 4th. The store will open at 8:00 a.m. Friday and Saturday and 9:00 a.m. Sunday.
On Friday, the first 100 people in line will be eligible for a free Reebok Play Dry® T-Shirt. Guests who are in line at 7:45am on Friday will get a chance to open the DICK’S Sporting Goods Gift Locker.
Dick’s Sporting Goods, Inc. operates as a sporting goods retailer primarily in the eastern United States. The company provides hardlines, counting sporting goods equipment, fitness equipment, golf equipment, and hunting and fishing gear products; apparel; and footwear products and accessories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
